Skip to content
Open access

Global burden and temporal trends of kidney cancer among children from 1990 to 2021: an analysis with projections to 2036

Jul 2026 · Frontiers in Pediatrics · Vol 14 · 0 citations · 47 references
Medicine

TL;DR

Inequality metrics showed that childhood KC mortality and DALYs were disproportionately concentrated in lower-SDI countries, and these disparities widened over time, yet the rising incidence in lower-income regions warrants attention.

Abstract

Background Childhood kidney cancer (KC), the third most prevalent pediatric solid malignancy, remains incompletely characterized in terms of epidemiological patterns and health inequities. This study aimed to analyze global trends, inequalities, and future burden of childhood KC from 1990 to 2021. Methods Data on incidence, mortality, and disability-adjusted life years (DALYs) of KC among children aged 0–14 years were obtained from the Global Burden of Disease study 2021. Data from 1990 to 2021 were comprehensively analyzed by sex, location, age, and socio-demographic index (SDI), incorporating estimated annual percentage change, joinpoint regression, slope index of inequality and concentration index for inequality assessment, and Bayesian age-period-cohort forecasting. Results In 2021, there were 9,576 incident cases, 3,063 deaths, and 268,049 DALYs globally due to childhood KC, with corresponding age-standardized incidence rate (ASIR), mortality rate (ASMR), and disability-adjusted life years rate (ASDR) of 0.48, 0.15, and 13.32, respectively. From 1990 to 2021, the global burden of childhood KC declined overall. Joinpoint regression identified a steeper decline in the most recent period, with the ASIR decreasing by 4.87% per year from 2018 to 2021 and the ASMR and ASDR decreasing by 5.12% and 5.23% per year, respectively, from 2019 to 2021. The decline in disease burden has been more pronounced in females than in males. The burden of childhood KC was mainly concentrated among children aged 0–4 years, whose age-specific incidence, mortality, and DALY rates were generally higher than those among children aged 5–9 years and 10–14 years. While no significant association was observed between SDI and ASIR, SDI exhibited a negative correlation with ASMR and ASDR. Inequality metrics showed that childhood KC mortality and DALYs were disproportionately concentrated in lower-SDI countries, and these disparities widened over time. Projections indicate continued declines in incidence and mortality for both sexes over the next 15 years. Conclusions Over the past three decades, the burden of childhood KC significantly reduced, yet the rising incidence in lower-income regions warrants attention. Health inequities, characterized by a disproportionate concentration of the disease burden in low-SDI countries, have intensified. Enhanced understanding of pediatric KC epidemiology may aid in its prevention and management.

Read PDF

Similar papers

Sep 2026

Global burden and inequality of childhood kidney cancer (1990–2050): a systematic analysis for the global burden of disease study 2021

Despite overall declines in the global burden of childhood kidney cancer, substantial disparities persist across sociodemographic contexts, and the importance of improving early diagnosis, access to standardized treatment, and delivery of pediatric oncology care in high-burden settings is emphasized.

Yan-Heng Sun, Qian Xu, Xin Dai et al. · 0 citations
Open access Jul 2026

Global burden of skin cancers and trends from 1990 to 2021: An observational study based on secondary analysis of GBD 2021

The study indicates that skin cancer remains an important public health issue worldwide and countries and regions should attach great importance to the prevention and treatment of skin cancers, and develop and improve preventive measures.

Ruosu Zhang, Yike Zhao, Yanling Li · 0 citations
Open access Jul 2026

Burden and temporal trends of cervical cancer in reproductive-age females from 1990 to 2021 and projections to 2035 in G20 countries: a systematic analysis of the Global Burden of Disease Study 2021.

Differentiated, evidence-based strategies tailored to national burden characteristics, addressing demographic shifts, key health system gaps, and human papillomavirus genotype disparities, are critically needed to successfully achieve the World Health Organization 2030 global cervical cancer elimination targets.

Xiang-Wen Li, Siyu Pan, Peng-Fei Qu et al. · 0 citations
Open access Aug 2026

Long-term trends and future projections of cervical cancer burden in China, 1990-2023: a Global Burden of Disease 2023 analysis.

Decomposition showed that population aging and growth offset favorable epidemiological changes, and projections suggested continued declines in ASDR with relatively stable deaths through 2045, underscore the urgent need to strengthen human papillomavirus vaccination coverage and expand equitable cervical cancer screeni...

Chao Ma, P. Yin, Nan Hong · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.